Background.
Despite the negative implications associated with a penicillin (PCN) allergy label, less than 0.1% of ~25 million subjects with PCN allergy undergo a PCN skin testing (PST) . There is a lack of data assessing patient knowledge and attitude about PCN allergy and PST. The purpose of this study was to evaluate the impact of an educational brochure on knowledge and perception of PST in adult inpatients with a PCN allergy label.
Methods. This was a pre-post intervention study conducted at a 528-bed community teaching hospital between June 2016 and March 2019. An electronic medical record was used to identify adult inpatients with an active PCN allergy. Participants completed a pre-brochure survey to assess demographic characteristics and baseline knowledge of PCN allergy and PST. Individuals then read an educational brochure, returned it to study personnel and were provided a post-brochure survey to complete. The primary and secondary outcomes of knowledge and perception were measured based on the level of agreement with statements about PCN allergies and PST using a 5-point Likert scale. McNemar's test was used to compare responses for those who agreed vs. did not agree to knowledge statements.
Results. Among 125 patients approached, 101 completed the survey (80.8%). Patients were predominantly female (66.3%), >65 years of age (42.6%), Caucasian (78.2%) and completed high school or beyond (81.2%). The minority of patients (40.6%) previously heard about PST while 25.7% agreed they had previous discussions about PST with a healthcare provider. Only 24.8% agreed that people can outgrow a PCN allergy at baseline; however, after reading the brochure, this percent tripled (77.2%) (P < 0.01). Among 56 participants who disagreed that PST would be helpful for them at baseline, 30 subsequently agreed with this statement on the post-brochure survey (P < 0.001). Post-brochure, 86.1% indicated they felt better informed about PST. Despite this, 34.7% indicated they would be scared to use PCN again if future PST results were negative.
Conclusion. An educational brochure improved general knowledge of PCN allergy and PST, including subject report of feeling more informed. Although the brochure successfully educated patients, gaps remain regarding how individuals will personally apply this new information.
Disclosures. All authors: No reported disclosures. Methods. This quasi-experimental study assessed patients with a self-reported penicillin allergy who were interviewed by APPE students from October 2018 through March 2019. Students on a 5-week infectious diseases rotation were trained in allergy assessment and interview skills by their preceptor and given a daily list of all inpatients with a self-reported penicillin allergy. After reviewing patients with the preceptor, the electronic health record was updated with specifics of the allergy, including the range, reaction, and any β-lactams tolerated since. Interventions included penicillin re-challenge, graded challenge, penicillin skin testing, desensitization, or removal or the allergy. The primary outcome was interventions attributed to APPE student patient interviews.
The Impact of Pharmacy Students Performing Penicillin Allergy Reconciliation in a Community Health System
Results. A total of 12 APPE students participated in the study. Reported reactions ranged from mild allergies (itching, rash) or adverse reactions (nausea, vomiting) to intermediate or severe allergies (hives, anaphylaxis). For the primary outcome there were 162 interventions performed, with 154 verbal, 2 re-challenges, and 6 skin tests. For the verbal interventions, 95 had their allergy updated, 34 removed, and 33 confirmed. None of the 8 patients who were skin tested or re-challenged had a subsequent reaction.
Conclusion. Pharmacy students can expand ASP allergy reconciliation services for patients with penicillin allergies in settings with limited resources. After proper training, students were effective in multiple aspects of allergy reconciliation with a significant number able to have their penicillin allergy removed.
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